Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Luo

Showing results (831-840 of 839) with videos related to

Pageof 84
Sort By:
You have reached the last page of results.This site can display upto 839 results.
Elife|June 25, 2013
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1Ling Luo, Hironori Uehara, Xiaohui Zhang, et al.
Gut|February 10, 2026
SDC1<sup>+</sup> CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancersGuan-Feng Gao, Zhao-Hui Ruan, Shi-Bo Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complicationsZongzhong Tong, Zhenglin Yang, Shrena Patel, et al.
The Journal of Clinical Investigation|July 8, 2020
Kinetics of viral load and antibody response in relation to COVID-19 severityYanqun Wang, Lu Zhang, Ling Sang, et al.
The New England Journal of Medicine|August 30, 2008
Toll-like receptor 3 and geographic atrophy in age-related macular degenerationZhenglin Yang, Charity Stratton, Peter J Francis, et al.
The Journal of Clinical Investigation|January 2, 2025
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinomaYanni Zeng, Chun-Ling Luo, Guo-Wang Lin, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 23, 2020
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple CohortsYun-Miao Guo, Jie-Rong Chen, Yan-Chun Feng, et al.
Pageof 84

Showing results (831-840 of 839) with videos related to

Sort By:
Pageof 84
You have reached the last page of results.This site can display upto 839 results.
Elife|June 25, 2013
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1Ling Luo, Hironori Uehara, Xiaohui Zhang, et al.
Gut|February 10, 2026
SDC1<sup>+</sup> CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancersGuan-Feng Gao, Zhao-Hui Ruan, Shi-Bo Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complicationsZongzhong Tong, Zhenglin Yang, Shrena Patel, et al.
The Journal of Clinical Investigation|July 8, 2020
Kinetics of viral load and antibody response in relation to COVID-19 severityYanqun Wang, Lu Zhang, Ling Sang, et al.
The New England Journal of Medicine|August 30, 2008
Toll-like receptor 3 and geographic atrophy in age-related macular degenerationZhenglin Yang, Charity Stratton, Peter J Francis, et al.
The Journal of Clinical Investigation|January 2, 2025
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinomaYanni Zeng, Chun-Ling Luo, Guo-Wang Lin, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer|July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 studyYa-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 23, 2020
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple CohortsYun-Miao Guo, Jie-Rong Chen, Yan-Chun Feng, et al.
Pageof 84